Edan Showcases Medical Innovations at MEDICA 2026

The Chinese medtech firm presented new imaging, monitoring and diagnostic systems at the Düsseldorf trade event in November.

Updated on Nov. 19, 2026 in Healthcare

Edan Showcases Medical Innovations at MEDICA 2026

Edan Instruments, Inc. presented its latest medical innovations at MEDICA 2026 in Düsseldorf, held November 16-19. The company showcased the Acclarix LX9S ultrasound system, the iV100 monitoring module and several laboratory analyzers.

Why it matters

The showcase signals Edan's push to expand its medical device portfolio in European markets through trade-show engagement with partners. For healthcare buyers, the range spans imaging, cardiac monitoring and lab diagnostics.

Edan reported a 23.8-inch display on the Acclarix LX9S, a 14-day continuous ECG capacity for its forthcoming Patch Holter, and a 6-part configuration on the H90 Series analyzer. Pricing, sales volumes and regulatory approval dates were not disclosed.

The players

Edan Instruments, Inc.

A Shenzhen-based global provider of medical devices and healthcare solutions, listed on the Shenzhen Stock Exchange under ticker 300206.SZ.

The details

At MEDICA 2026, Edan featured the Acclarix LX9S, powered by the SynSight zone sonography platform and a new eSRI imaging algorithm. The company also highlighted the iV100 transport and multi-parameter module, Smart ECG Web for centralized cardiac data across facilities, and the EDAN i500 blood gas analyzer with co-oximetry and auto-QC.

Timeline

  1. November 16-19, 2026: MEDICA 2026 trade event held in Düsseldorf, Germany.

Market Landscape

Edan's appearance at MEDICA, the largest annual medical trade fair in Düsseldorf, places a Chinese device maker alongside established European and American competitors in a crowded imaging and diagnostics market. Its emphasis on AI-assisted ultrasound and connected cardiac monitoring reflects broader competition in those segments.

For hospitals and clinics evaluating imaging and monitoring equipment, Edan's new systems add options from a Chinese manufacturer to procurement shortlists. Practical adoption will depend on regional regulatory clearances and local service availability, which the company did not detail.

The takeaway

Medical device buyers should watch for regulatory clearance and local distribution details before weighing Edan's newly previewed systems against established suppliers.

Further reading

Explore more Healthcare coverage on Wisevoter.

Source note: This article includes information reported by AFP.